PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Clinical Pharmacology that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.
Laura Ruth Alder, MD / Puneeth Iyengar, MD, PhD / Pooja Karukonda, MD - Shifting the Status Quo in LS-SCLC: The Practicalities of Integrating Immunotherapy Into Treatment Pathways
For the complete activity, including supporting material, please visit https://www.peervoice.com/ZCX860. Presented by Laura Ruth Alder, MD; Puneeth Iyengar, MD, PhD; and Pooja Karukonda, MD. Learning Objectives: Describe the clinical and radiographic criteria used to define limited-stage small cell lung cancer (LS-SCLC) and common pitfalls encountered in real-world practice; Summarize recent evidence and guideline changes in LS-SCLC management, including subgroup-specific considerations; Integrate patient response, treatment regimen, and multidisciplinary input to determine eligibility, timing, and duration of consolidation immunotherapy in real-world LS-SCLC care; Describe strategies for differentiating disease progression versus treatment-associated pneumonitis in patients receiving immunotherapy for LS-SCLC and implications for anti-cancer treatment decisions.
8 Oct 2026
Sheila Wijayasinghe, MD, CCFP, MSCP - Where Change Begins: Why and How the Power of Primary Care Can Combat the Disruptive Symptoms of Menopause
For the complete activity, including supporting material, please visit https://www.peervoice.com/UJY860. Presented by Sheila Wijayasinghe, MD, CCFP, MSCP. Learning Objectives: Identify common assumptions and misconceptions about menopause and their potential consequences on patient care; Explain the advantages and limitations of menopausal hormone therapy (MHT) and non-hormonal pharmacological treatments for vasomotor symptoms and sleep disturbances associated with menopause; Demonstrate the ability to elicit patient priorities and preferences and incorporate this information into individualised, patient-centred management decisions.
22 Sept 2026
Eileen M. O'Reilly, MD, FASCO - Hope Is on the Horizon: Anticipating Novel Treatment Approaches in Advanced Pancreatic Cancer
For the complete activity, including supporting material, please visit https://www.peervoice.com/RAZ860. Presented by Eileen M. O'Reilly, MD, FASCO. Learning Objectives: Recognise patient-reported burdens associated with the diagnosis of advanced pancreatic cancer and how these impact decisions surrounding treatment; Identify therapeutic agents under investigation for the management of advanced pancreatic cancer and their current state of development; Implement current, evidence-based best practices in the management of advanced pancreatic cancer, including providing appropriate mental health support to patients.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
3 ratings
Host of PeerVoice Clinical Pharmacology Audio?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
